| abstract |
This invention provides compounds defined by Formula I or a pharmaceuticafy acceptable salt theme, wherein R1, Q, Y3, Y4, Y5, Y6, Y8, R2, and R4 are as defined in the specification. The invention also provides pharmaceutical compositions comprising a compounnd of Formula I and the use of the compounds of Formula I as matrix metalloproteinase inhibitors. |